LABCORP HOLDINGS INC.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 20 trades on this page.
EVP, CIO & CTO
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, COO
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP and President, Diagnostics
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, Pres of BLS, CMO & CSO
Restricted Stock Unit
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
SVP, Chief Accounting Officer
Common Stock
SVP, Chief Accounting Officer
Non-qualified Stock Options
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP, Chief Legal Officer
Common Stock
EVP, Chief Legal Officer
Common Stock
EVP, Chief Legal Officer
Restricted Stock Unit
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
EVP and President, Diagnostics
Common Stock
EVP and President, Diagnostics
Common Stock
EVP and President, Diagnostics
Restricted Stock Unit
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
President & CEO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & CEO
Common Stock
EVP, CHRO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, CHRO
Common Stock
EVP, Pres Diagnostics & COO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, Pres Diagnostics & COO
Common Stock
EVP, Pres Diagnostics & COO
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
EVP, Pres Diagnostics & COO
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP, CIO & CTO | Restricted Stock UnitGrant or award | Derivative units750Award · no purchase price | Non-cash award | Sep 1Filed Sep 3 · 2d later | SEC filing |
| EVP, COO | Restricted Stock UnitGrant or award | Derivative units900Award · no purchase price | Non-cash award | Sep 1Filed Sep 3 · 2d later | SEC filing |
| EVP and President, Diagnostics | Restricted Stock UnitGrant or award | Derivative units1,500Award · no purchase price | Non-cash award | Sep 1Filed Sep 3 · 2d later | SEC filing |
| EVP, Pres of BLS, CMO & CSO | Restricted Stock UnitGrant or award | Derivative units3,000Award · no purchase price | Non-cash award | Sep 1Filed Sep 3 · 2d later | SEC filing |
| SVP, Chief Accounting Officer | Common StockOption exercise or conversion | 1,338$209.25 / share | $279.98K | Aug 3Filed Aug 5 · 2d later | SEC filing |
| SVP, Chief Accounting Officer | Non-qualified Stock OptionsOption exercise or conversion | Derivative units1,338$209.25 exercise / conversion price | Not a separate purchase | Aug 3Filed Aug 5 · 2d later | SEC filing |
| EVP, Chief Legal Officer | Common StockOption exercise or conversion10b5-1 | 256Price not reported | Unavailable | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP, Chief Legal Officer | Common StockExercise-price or tax withholding10b5-1 | 73$283.88 / share | $20.72K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP, Chief Legal Officer | Restricted Stock UnitOption exercise or conversion10b5-1 | Derivative units256Exercise / conversion price not reported | Not a separate purchase | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP and President, Diagnostics | Common StockOption exercise or conversion10b5-1 | 327Price not reported | Unavailable | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP and President, Diagnostics | Common StockExercise-price or tax withholding10b5-1 | 93$283.88 / share | $26.4K | Jul 1Filed Jul 6 · 5d later | SEC filing |
| EVP and President, Diagnostics | Restricted Stock UnitOption exercise or conversion10b5-1 | Derivative units327Exercise / conversion price not reported | Not a separate purchase | Jul 1Filed Jul 6 · 5d later | SEC filing |
| President & CEO | Common StockGrant or award | 58,470Award · no purchase price | Non-cash award | Mar 26Filed Mar 30 · 4d later | SEC filing |
| President & CEO | Common StockExercise-price or tax withholding | 26,106$268.38 / share | $7.01M | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, CHRO | Common StockGrant or award | 6,604Award · no purchase price | Non-cash award | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, CHRO | Common StockExercise-price or tax withholding | 2,879$268.38 / share | $772.67K | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, Pres Diagnostics & COO | Common StockGrant or award | 9,304Award · no purchase price | Non-cash award | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, Pres Diagnostics & COO | Common StockExercise-price or tax withholding | 4,600$268.38 / share | $1.23M | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, Pres Diagnostics & COO | Common StockGrant or award | 2,968Award · no purchase price | Non-cash award | Mar 26Filed Mar 30 · 4d later | SEC filing |
| EVP, Pres Diagnostics & COO | Common StockExercise-price or tax withholding | 1,468$268.38 / share | $393.98K | Mar 26Filed Mar 30 · 4d later | SEC filing |
Showing the latest 20 of 40 trades. Show all 40 trades
Labcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a sale for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a partial sale for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock · Stock
The filing reports a purchase for the member.
Labcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberLabcorp Holdings Inc. Common Stock (LH) · Stock
The filing reports a purchase for a dependent.
April McClain DelaneyReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
